These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 5651509)

  • 1. Behavioral and biochemical alterations in schizophrenic patients.
    Spaide J; Tanimukai H; Bueno JR; Himwich HE
    Arch Gen Psychiatry; 1968 Jun; 18(6):658-65. PubMed ID: 5651509
    [No Abstract]   [Full Text] [Related]  

  • 2. Detection of psychotomimetic N,N-dimethylated indoleamines in the urine of four schizophrenic patients.
    Tanimukai H; Ginther R; Spaide J; Bueno JR; Himwich HE
    Br J Psychiatry; 1970 Oct; 117(539):421-30. PubMed ID: 5312352
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparative behavioral and biochemical effects of tranylcypromine and cysteine on normal controls and schizophrenic patients.
    Narasimhachari N; Heller B; Spaide J; Haskovec L; Fujimori M; Tabushi K; Himwich HE
    Life Sci I; 1970 Sep; 9(18):1021-32. PubMed ID: 5478406
    [No Abstract]   [Full Text] [Related]  

  • 4. Urinary studies of schizophrenics and controls.
    Narasimhachari N; Heller B; Spaide J; Haskovec L; Fujimori M; Tabushi K; Himwich HE
    Biol Psychiatry; 1971; 3(1):9-20. PubMed ID: 4398666
    [No Abstract]   [Full Text] [Related]  

  • 5. The determination of bufotenin in urine of schizophrenic patients and normal controls.
    Narasimhachari N; Himwich HE
    J Psychiatr Res; 1972 Jun; 9(2):113-21. PubMed ID: 5071936
    [No Abstract]   [Full Text] [Related]  

  • 6. Occurrence of bufotenin (5-hydroxy-N,N-dimethyltryptamine) in urine of schizophrenic patients.
    Tanimukai H; Ginther R; Spaide J; Bueno JR; Himwich HE
    Life Sci; 1967 Aug; 6(16):1697-706. PubMed ID: 6057885
    [No Abstract]   [Full Text] [Related]  

  • 7. Methionine and tryptophan loading in schizophrenic patients receiving a MAO inhibitor: correlation of behavioral and biochemical changes.
    Spaide J; Neveln L; Tolentino J; Himwich HE
    Biol Psychiatry; 1969 Jul; 1(3):227-33. PubMed ID: 5352654
    [No Abstract]   [Full Text] [Related]  

  • 8. Schizophrenic behavior and urinary tryptophan metabolites associated with cysteine given with and without a monoamine oxidase inhibitor (tranylcypromine).
    Spaide J; Tanimukai H; Ginther R; Bueno J; Himwich HE
    Life Sci; 1967 Mar; 6(5):551-60. PubMed ID: 4226702
    [No Abstract]   [Full Text] [Related]  

  • 9. [N,N-dimethyltryptamine and bufotenin in the urine of patients with chronic and acute schizophrenic psychoses].
    Rosengarten H; Szemis A; Piotrowski A; Romaszewska K; Matsumoto H; Stencka K; Jus A
    Psychiatr Pol; 1970; 4(5):519-21. PubMed ID: 5483205
    [No Abstract]   [Full Text] [Related]  

  • 10. Studies of drug-free schizophrenics and controls.
    Narasimhachari N; Avalos J; Fujimori M; Himwich HE
    Biol Psychiatry; 1973 Dec; 5(3):311-8. PubMed ID: 4513564
    [No Abstract]   [Full Text] [Related]  

  • 11. Methylated psychotogens in the urine of psychiatric patients.
    Kanabus P; Krysa G; Matsumoto H; Stencka K
    Act Nerv Super (Praha); 1973 May; 15(2):124. PubMed ID: 4518608
    [No Abstract]   [Full Text] [Related]  

  • 12. [Endogenous hallucinogens].
    Kanabus P; Frindt-Zajaczkowska A
    Psychiatr Pol; 1974; 8(2):197-202. PubMed ID: 4830327
    [No Abstract]   [Full Text] [Related]  

  • 13. Gas chromatographic-mass spectrometric identification of urinary bufotenin and dimethyltryptamine in drug-free chronic schizophrenic patients.
    Narasimhachari N; Baumann P; Pak HS; Carpenter WT; Zocchi AF; Hokanson L; Fujimori M; Himwich HE
    Biol Psychiatry; 1974 Jun; 8(3):293-305. PubMed ID: 4527813
    [No Abstract]   [Full Text] [Related]  

  • 14. A biochemical study of early infantile austism.
    Himwich HE; Jenkins RL; Fujimori M; Narasimhachari N; Ebersole M
    J Autism Child Schizophr; 1972; 2(2):114-26. PubMed ID: 5068665
    [No Abstract]   [Full Text] [Related]  

  • 15. Urinary amines in chronic schizophrenia.
    Perry TL; Hansen S; MacDougall L
    Nature; 1966 Oct; 212(5058):146-8. PubMed ID: 5339580
    [No Abstract]   [Full Text] [Related]  

  • 16. Gas chromatographic-mass spectrometric identification of N:N-dimethyltryptamine in urine samples from drug-free chronic schizophrenic patients and its quantitation by the technique of single (selective) ion monitoring.
    Narasimhachari N; Himwich HE
    Biochem Biophys Res Commun; 1973 Dec; 55(4):1064-71. PubMed ID: 4520847
    [No Abstract]   [Full Text] [Related]  

  • 17. [Correlation between disturbances of tryptophan metabolism induced by methionine and nialamide administration and changes of the mental state in chronic schizophrenic patients].
    Jus A; Rosengarten H; Wardaszko-Lyskowska H; Szemis A; Stencka K; Wlosińska I; Krzyzowski J; Kowalska K
    Psychiatr Pol; 1970; 4(4):365-71. PubMed ID: 5472573
    [No Abstract]   [Full Text] [Related]  

  • 18. Psychotogenic N,N-Dimethylated indole amines and behavior in schizophrenic patients.
    Tanimukai H; Ginther R; Spaide J; Bueno JR; Himwich HE
    Recent Adv Biol Psychiatry; 1968; 10():6-15. PubMed ID: 4873523
    [No Abstract]   [Full Text] [Related]  

  • 19. Excretion of indoleamines in schizophrenia.
    Bueno JR; Himwich HE
    Int J Neurol; 1967; 6(1):65-76. PubMed ID: 5622712
    [No Abstract]   [Full Text] [Related]  

  • 20. Debrisoquin, a selective inhibitor of intraneuronal monoamine oxidase in man.
    Pettinger WA; Korn A; Spiegel H; Solomon HM; Pocelinko R; Abrams WB
    Clin Pharmacol Ther; 1969; 10(5):667-74. PubMed ID: 5808462
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.